Synapse Open Synapse
Wellbeing

Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report

NYT Well ·

Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.

Same story elsewhere

Latest from NYT Well